Cambrex to Present at the 2017 UBS Global Healthcare Conference
May 15 2017 - 1:00PM
Cambrex Corporation (NYSE:CBM), a leading manufacturer of small
molecule innovator and generic Active Pharmaceutical Ingredients
(APIs), today announced that Steven Klosk, President and Chief
Executive Officer, will present at the 2017 UBS Global Healthcare
Conference on May 22, 2017 at 10:30 a.m. EDT in New York City.
The live audio webcast and slide presentation
can be accessed from the Cambrex website at www.cambrex.com in the
Investors section under “Webcasts & Presentations”, and a
replay will be available for 90 days after the live event
concludes.
About
Cambrex
Cambrex Corporation is an innovative life
sciences company that provides products, services and technologies
to accelerate the development and commercialization of small
molecule therapeutics. The Company offers Active
Pharmaceutical Ingredients (APIs), advanced intermediates and
enhanced drug delivery products for branded and generic
pharmaceuticals. Development and manufacturing capabilities include
enzymatic biotransformations, high potency APIs, high energy
chemical synthesis and controlled substances. For more
information, please visit www.cambrex.com.
Contact:
Stephanie LaFiura
IR Associate
Tel: +201 804 3037
Email: stephanie.lafiura@cambrex.com
Cambrex (NYSE:CBM)
Historical Stock Chart
From Apr 2024 to May 2024
Cambrex (NYSE:CBM)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Cambrex Corp (New York Stock Exchange): 0 recent articles
More News Articles